𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

✍ Scribed by D. Russell-Jones; A. Vaag; O. Schmitz; B. K. Sethi; N. Lalic; S. Antic; M. Zdravkovic; G. M. Ravn; R. Simó; on behalf of the Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Study Group


Publisher
Springer
Year
2009
Tongue
English
Weight
193 KB
Volume
52
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.